The transcription factor RFX5 is a transcriptional activator of the TPP1 gene in hepatocellular carcinoma
Yangjing Zhao(Jiangsu University), Hongsong Chen(Inner Mongolia University for Nationalities), Qixiang Shao(Jiangsu University), Weijia Liao(Guilin Medical University), Xingwang Xie(Peking University), Xueyan Wang(Peking University), Ran Fei(Peking University), Hui Cao(First Affiliated Hospital Zhejiang University), Henghui Zhang(Nanfang Hospital), Lai Wei(Nanjing University of Finance and Economics)
Cited by 50
Related Papers
New progress in the pharmacology of protocatechuic acid: A compound ingested in daily foods and herbs frequently and heavily
|Pharmacological Research|2020|301
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2015|271
Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
|Drug Resistance Updates|2023|202
Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease
|Frontiers in Immunology|2022|122
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease
|Journal of Hepatology|2021|118